Founded in 1991, the Group has facilities that allow full coverage of the territory, in terms of sales, laboratories, show rooms, customer support and warehousing. All buildings are the property of the Group:
Alimos (Athens): 4-storey building, 500 m²
Koropi (Near the new Athens Airport): 6.250 m² land and 1170m² of housed space, including offices, Molecular Analysis Laboratories, Production and warehousing.
Thessaloniki: 3-storey building, 400m². Houses the group’s sales and service activities for coverage of Northern Greece.
ISO 9001:2008 & ISO 13485 Certifiied
CE-IVD Mark for products manufactured.
Total staff: 30 (of which sales staff:13). Qualifications of Sales and Applications Staff: 4 PhD in Biology. 9 BS in Biology or Chemistry. Service Engineers: 6.
Target Partners & Collaborations
Interest in novel IVD technology platforms and in commercialization of therapeutic and prognostic biomarkers for personalized medicine in Autoimmune Diseases & Oncology.
Technologies / Services offered or sought
Contract Manufacturing for IVD products
Molecular Analysis and Flow-Cytomtery R&D Services
Development of Companion Diagnostics
Technology and R&D
P. Zafiropoulos S.A.'s current fields of action and interest are:
Medical devices and equipment, with emphasis on Reagents for Research and Diagnostics.
Scientific products addressing the Research and Industrial market
Manufacture of Diagnostic Reagents
Clients & Collaborations (NATIONAL)
ATTIKON UNIVERSITY HOSPITAL OF ATHENS
MEDICAL SCHOOL OF ATHENS UNIVERSITY
ALEXANDER FLEMING RESEARCH INSTITUTION
MEDICAL SCHOOL OF THE UNIVERSITY OF IOANNINA
Centre for Research and Technology - Hellas (CERTH) - INSTITUTE OF APPLIED BIOSCIENCES (INAB)
School of National Technical University of Athens – BIOMEDICAL ENGINEERING LABORATORY OF THE ELECTRICAL & COMPUTER ENINEERING